Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neeraj Dhar

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
Research Square|November 24, 2025
Saskemycin, a potent and selective antimycobacterial agent targeting a unique site on the ribosomeGerard Wright, Michael Cook, Min Xu, et al.
ACS Chemical Biology|November 27, 2014
2-Carboxyquinoxalines kill mycobacterium tuberculosis through noncovalent inhibition of DprE1João Neres, Ruben C Hartkoorn, Laurent R Chiarelli, et al.
Molecular Microbiology|September 29, 2016
Identification of aminopyrimidine-sulfonamides as potent modulators of Wag31-mediated cell elongation in mycobacteriaVinayak Singh, Neeraj Dhar, János Pató, et al.
Science (New York, N.Y.)|March 21, 2009
Benzothiazinones kill Mycobacterium tuberculosis by blocking arabinan synthesisVadim Makarov, Giulia Manina, Katarina Mikusova, et al.
Ebiomedicine|July 19, 2016
Antitubercular drugs for an old target: GSK693 as a promising InhA direct inhibitorMaría Martínez-Hoyos, Esther Perez-Herran, Gulcin Gulten, et al.
Journal of Medicinal Chemistry|May 30, 2014
4-aminoquinolone piperidine amides: noncovalent inhibitors of DprE1 with long residence time and potent antimycobacterial activityMaruti Naik, Vaishali Humnabadkar, Subramanyam J Tantry, et al.
Nature|June 18, 2025
Targeting de novo purine biosynthesis for tuberculosis treatmentDirk A Lamprecht, Richard J Wall, Annelies Leemans, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2026
Menaquinone depletion resensitises bedaquiline-resistant tuberculosisJennefer Wetzel, John Dallow, Ellie Davis, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Research Square|November 24, 2025
Saskemycin, a potent and selective antimycobacterial agent targeting a unique site on the ribosomeGerard Wright, Michael Cook, Min Xu, et al.
ACS Chemical Biology|November 27, 2014
2-Carboxyquinoxalines kill mycobacterium tuberculosis through noncovalent inhibition of DprE1João Neres, Ruben C Hartkoorn, Laurent R Chiarelli, et al.
Molecular Microbiology|September 29, 2016
Identification of aminopyrimidine-sulfonamides as potent modulators of Wag31-mediated cell elongation in mycobacteriaVinayak Singh, Neeraj Dhar, János Pató, et al.
Science (New York, N.Y.)|March 21, 2009
Benzothiazinones kill Mycobacterium tuberculosis by blocking arabinan synthesisVadim Makarov, Giulia Manina, Katarina Mikusova, et al.
Ebiomedicine|July 19, 2016
Antitubercular drugs for an old target: GSK693 as a promising InhA direct inhibitorMaría Martínez-Hoyos, Esther Perez-Herran, Gulcin Gulten, et al.
Journal of Medicinal Chemistry|May 30, 2014
4-aminoquinolone piperidine amides: noncovalent inhibitors of DprE1 with long residence time and potent antimycobacterial activityMaruti Naik, Vaishali Humnabadkar, Subramanyam J Tantry, et al.
Nature|June 18, 2025
Targeting de novo purine biosynthesis for tuberculosis treatmentDirk A Lamprecht, Richard J Wall, Annelies Leemans, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2026
Menaquinone depletion resensitises bedaquiline-resistant tuberculosisJennefer Wetzel, John Dallow, Ellie Davis, et al.
Pageof 8